全球角膜产品市场（2024）：2023-2029年分析

全球角膜产品市场（2024）新增福斯氏角膜内皮细胞失养症的全球市场机会相关部分，依地区分析福斯氏角膜内皮细胞失养症替代治疗机会的潜在市场影响，并提供前10国家潜在市场的关键指标。

更新了六类 52 种疾病的角膜疾病人口的估计和预测，并修改了对可从角膜移植中受益的总人口的预测。

2024年角膜产品市场概览概述了角膜疾病以及六种疾病类别的人口预测。讨论了角膜产品和程序，包括角膜移植、治疗水晶体、PTK、角膜内环段和角膜交联，以及收入预测。也回顾了器官捐赠政策、法规和政策，以及角膜专家、眼库和其他组织的角色。

本报告在其市场预测中考虑了来自50多家公司的70多种产品，同时也讨论了即将推出的、其收入尚未预测的新技术。它还介绍了数百家眼库、研究机构和非政府组织。还包括12个主要市场参与者的详细公司简介。

本报告涵盖了整个角膜治疗市场，网罗从疾病人口到生产产品的公司。

目录

• 有关角膜疾病的资讯
• 角膜疾病族群现况及5年预测
• 外耳炎
• 角膜营养不良
• 先天性角膜疾病
• 后天性角膜疾病与外伤
• 传染性角膜疾病
• 角膜炎
• 神经营养性角膜炎
• 其他角膜症候群和併发症
• 关于全球法规与器官移植环境的讨论
• 有关眼科医生、角膜专家和角膜移植外科医生的资讯
• 光治疗性角膜切除术地区预测
• 各地区治疗镜片预测
• 依地区的角膜内环节段预测
• 依地区的角膜交联预测
• 依地区的角膜移植预测
• 依手术技术的角膜移植预测
• 依适应症的角膜移植预测
• 深入了解开发的新产品
• 关键产品与公司见解

What's New:

The "2024 Cornea Products Market Report" features a new section on the global market opportunity for Fuchs' dystrophy treatment, examining the potential market impact of alternate Fuchs' dystrophy treatment opportunity by region and presenting key metrics for the top 10 potential markets.

The report also includes updated estimates for population with corneal disease for six categories and 52 diseases and a revised forecast for the total population that could benefit from a cornea transplant, with breakouts for those with access to ophthalmic care and those who could benefit from upcoming therapies.

The "2024 Cornea Products Market Report" provides an overview of corneal diseases and gives estimates for the populations in six disease categories. The report discusses cornea products and treatments and revenue forecasts for cornea transplants, therapeutic lenses, PTK, intrastromal corneal ring segments, and corneal crosslinking. It also reviews organ donation policy, regulations, and the role of cornea specialists, eye banks, and other organizations.

This report considers over 70 products from more than 50 companies in its market forecasts and discusses the upcoming pipeline of new technologies that have yet to recognize revenue. Hundreds of eye banks, research institutes, and NGOs are also considered. Also included are 12 in-depth company profiles on key market players.

Contents:

This new report covers the entire cornea treatment landscape-from the diseased populations to the companies manufacturing the products. Our coverage includes:

• Information on corneal diseases
• Current and five-year estimates for the population with corneal diseases
• Ectasias
• Corneal dystrophies
• Congenital corneal disease
• Acquired corneal diseases and trauma
• Infectious corneal diseases
• Keratitis
• Neurotrophic keratitis
• Other corneal syndromes and complications
• Discussion on the global regulatory and organ transplantation environment
• Information on ophthalmologists, cornea specialists, and cornea transplant surgeons
• Forecasts for phototherapeutic keratectomy procedures by region
• Forecasts for therapeutic lenses by region
• Forecasts for intrastromal corneal ring segments by region
• Forecasts for corneal crosslinking by region
• Forecasts for cornea transplants by region
• Forecasts for cornea transplants by surgical technique
• Forecasts for cornea transplants by indication
• Discussion of new products in development
• Discussion of key products and companies